RESULTS FROM A PHASE I/II TRIAL OF TINOSTAMUSTINE MONOTHERAPY IN ADVANCED SOLID TUMOURS (NCT03345485): SAFETY AND EFFICACY IN A SUBSET OF PATIENTS WITH ADVANCED OVARIAN CANCER (OVCA)

被引：0
|
作者：
Tinker, Anna V. [1 ]
Chugh, Rashmi [2 ]
Curigliano, Giuseppe [3 ]
Kummar, Shivaani [4 ]
Schneider, Reva [5 ]
Strauss, James [5 ]
Janik, Tomas [6 ]
Manamley, Nick [6 ]
Hilgier, Kasia [6 ]
Oaknin, Ana [7 ]
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA
[3] European Inst Oncol, IRCCS, Milan, Italy
[4] Oregon Hlth & Sci Univ, Portland, OR USA
[5] Mary Crowley Canc Res, Dallas, TX USA
[6] Mundipharma Res Ltd, Cambridge, England
[7] Hosp Univ Vall Hebron, Gynaecol Canc Programme, Vall Hebron Inst Oncol VHIO, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
163
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [41] PHASE I/II TRIAL OF CABOZANTINIB PLUS DURVALUMAB IN ADVANCED GASTROESOPHAGEAL CANCER AND OTHER GASTROINTESTINAL MALIGNANCIES (CAMILLA): PHASE IB SAFETY AND EFFICACY RESULTS
    Saeed, Anwaar
    Park, Robin
    Dai, Junqiang
    Al-Rajabi, Raed
    Kasi, Anup
    Baranda, Joaquina
    Williamson, Stephen
    Collins, Zachary
    Ripp, Jacob
    Saeed, Azhar
    Mulvaney, Kelly
    Manirad, Vanna
    Madan, Rashna
    Subramaniam, Dharmalingam
    Anant, Shrikant
    Phadnis, Milind
    Sun, Weijing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A372 - A372
  • [42] Efficacy and safety of oxaliplatin combined with capecitabine as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: A prospective phase II trial (NCT02415829)
    Liu, F.
    Yang, L.
    Huang, D.
    Wang, L.
    Xu, J.
    Xu, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S346 - S346
  • [43] Safety and efficacy of a phase I/IIa trial (NCT03066947) of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer.
    Williams, William
    Holmes, Jarrod P.
    Bhattacharya, Saveri
    Calfa, Carmen
    Dakhil, Shaker R.
    Lukas, Jason Jerome
    Tan-Chiu, Elizabeth
    Adams, Daniel
    Peoples, George
    Lacher, Markus
    Wiseman, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Phase I/II study of biweekly pemetrexed plus cisplatin in patients with locally advanced, nonresectable or metastatic urothelial cancer: Safety and efficacy results from phase II.
    Lopez Martin, Ana
    Bellmunt, Joaquim
    Pablo Maroto, Jose
    Gallardo, Enrique
    Lopez Brea, Marta
    Luis Perez-Gracia, Jose
    Castellano, Daniel E.
    Maria Valverde, Claudia
    Bezares, Susana
    Calvo, Emiliano
    Paz-Ares, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Safety and efficacy of gefitinib monotherapy for patients (pts) ≥80 years (yrs) with advanced non-small cell lung cancer (NSCLC): A phase II subset analysis
    Ebi, N.
    Semba, H.
    Tokunaga, S.
    Takayama, K.
    Wataya, H.
    Kuraki, T.
    Yamamoto, H.
    Akamine, S.
    Okamoto, I.
    Nakanishi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Phase I clinical trial investigating maximum tolerated dose, safety and pharmacokinetics of volasertib in Japanese patients with advanced solid tumours
    Nokihara, H.
    Yamamoto, N.
    Fujiwara, Y.
    Yamada, Y.
    Wakui, H.
    Nakamichi, S.
    Kitazono, S.
    Taube, T.
    Takeuchi, Y.
    Tamura, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S183 - S183
  • [47] Docetaxel (D) and oxaliplatin (DOCELOX) in advanced ovarian cancer (AOC): Preliminary safety results of a phase I-II.
    Tournigand, C
    Carola, E
    Goebel, FM
    Bennamoun, M
    Garcia, ML
    Gervais, H
    Perez, N
    Plantade, A
    Louvet, C
    de Gramont, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 480S - 480S
  • [48] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [49] BRIVANIB (B) IN ADVANCED OVARIAN CANCER (OC): SUBSET RESULTS OF A PHASE 2 RANDOMIZED DISCONTINUATION TRIAL (RDT)
    Kaye, S. B.
    Siu, L. L.
    Jassem, J.
    Medioni, J.
    Soetekouw, P. M. M. B.
    Slater, S.
    Rudin, C. M.
    Schwartz, G. K.
    De Jonge, M.
    O'Dwyer, P.
    Baudelet, C.
    Chen, A.
    Ratain, M. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 319 - 319
  • [50] Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer
    Akerley, W
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 55 - 58
12345